Evidence map›Paper›PMID 38225559›Full record

ArticleBMC pregnancy and childbirth2024

Early to mid-pregnancy HbA1c levels and its association with adverse pregnancy outcomes in three low middle-income countries in Asia and Sub-Saharan Africa.

Muhammad Imran Nisar, Sayan das, Rasheda Khanam, Javairia Khalid, Swagata Chetia, Tarik Hasan, Shahira Shahid, Msafiri Ladislaus Marijani, Salahuddin Ahmed, Farah Khalid and 18 more

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Muhammad Imran Nisar *Department of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Sayan das *Center for Public Health Kinetics, New Delhi, India.
Rasheda Khanam *Department of International Health, Johns Hopkins Bloomberg School of Public Health, Maryland, Baltimore, USA.
Javairia KhalidDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Swagata ChetiaCenter for Public Health Kinetics, New Delhi, India.
Tarik HasanProjahnmo Research Foundation, Dhaka, Bangladesh.
Shahira ShahidDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Msafiri Ladislaus MarijaniMinistry of Health, Zanzibar, Tanzania.
Salahuddin AhmedProjahnmo Research Foundation, Dhaka, Bangladesh.
Farah KhalidDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Said Mohammed AliPublic Health Laboratory-IDC, Pemba, Tanzania.
Nabidul Haque ChowdhuryProjahnmo Research Foundation, Dhaka, Bangladesh.
Usma MehmoodDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Arup DuttaCenter for Public Health Kinetics, New Delhi, India.
Sayedur RahmanDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Muhammad Farrukh QaziDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Saikat DebCenter for Public Health Kinetics, New Delhi, India.
Dipak Kumar MitraDepartment of Public Health, School of Health and Life Sciences, North South University, Dhaka, Bangladesh.
Asra Abeer UsmaniDepartment of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
Usha DhingraCenter for Public Health Kinetics, New Delhi, India.
Rubhana RaqibInternational Center for Diarrheal Disease Research, Dhaka, Bangladesh.
Alexander ManuLondon School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK.
Sachiyo YoshidaDepartment for Maternal, Child, Adolescents and Ageing Health, World Health Organization (MCA/MRD), Avenue Appia 20, Geneva, 1211, Switzerland. yoshidas@who.int.
Nicole MinckasDepartment for Maternal, Child, Adolescents and Ageing Health, World Health Organization (MCA/MRD), Avenue Appia 20, Geneva, 1211, Switzerland.
Rajiv BahlDepartment for Maternal, Child, Adolescents and Ageing Health, World Health Organization (MCA/MRD), Avenue Appia 20, Geneva, 1211, Switzerland.
Abdullah H Baqui *Department of International Health, Johns Hopkins Bloomberg School of Public Health, Maryland, Baltimore, USA.
Sunil Sazawal *Center for Public Health Kinetics, New Delhi, India.
Fyezah Jehan *Department of Pediatrics and Child Health, The Aga Khan University, Stadium Road, Karachi, 74800, Pakistan. fyezah.jehan@aku.edu.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundHyperglycemia during pregnancy leads to adverse maternal and fetal outcomes. Thus, strict monitoring of blood glucose levels is warranted. This study aims to determine the association of early to mid-pregnancy HbA1c levels with the development of pregnancy complications in women from three countries in South Asia and Sub-Saharan Africa.

methodsWe performed a secondary analysis of the AMANHI (Alliance for Maternal and Newborn Health Improvement) cohort, which enrolled 10,001 pregnant women between May 2014 and June 2018 across Sylhet-Bangladesh, Karachi-Pakistan, and Pemba Island-Tanzania. HbA1c assays were performed at enrollment (8 to < 20 gestational weeks), and epidemiological data were collected during 2-3 monthly household visits. The women were followed-up till the postpartum period to determine the pregnancy outcomes. Multivariable logistic regression models assessed the association between elevated HbA1c levels and adverse events while controlling for potential confounders.

resultsA total of 9,510 pregnant women were included in the analysis. The mean HbA1c level at enrollment was found to be the highest in Bangladesh (5.31 ± 0.37), followed by Tanzania (5.22 ± 0.49) and then Pakistan (5.07 ± 0.58). We report 339 stillbirths and 9,039 live births. Among the live births were 892 preterm births, 892 deliveries via cesarean section, and 532 LGA babies. In the multivariate pooled analysis, maternal HbA1c levels of ≥ 6.5 were associated with increased risks of stillbirths (aRR = 6.3, 95% CI = 3.4,11.6); preterm births (aRR = 3.5, 95% CI = 1.8-6.7); and Large for Gestational Age (aRR = 5.5, 95% CI = 2.9-10.6).

conclusionMaternal HbA1c level is an independent risk factor for predicting adverse pregnancy outcomes such as stillbirth, preterm birth, and LGA among women in South Asia and Sub-Saharan Africa. These groups may benefit from early interventional strategies.

Indexed as

Pregnancy OutcomePremature BirthBangladeshCesarean SectionDeveloping CountriesFemaleGlycated HemoglobinHumansInfant, NewbornPakistanPregnancyStillbirthTanzaniaGlycated HemoglobinAdverse pregnancy outcomesFirst trimesterGestational Diabetes MellitusHbA1cLMICsSouth AsiaSub-Saharan Africa

Identifiers

PMID38225559
PMCPMC10789021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.